Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$33.11 - $55.01 $14.5 Million - $24.1 Million
-437,951 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$50.07 - $66.05 $823,851 - $1.09 Million
-16,454 Reduced 3.62%
437,951 $21.9 Million
Q2 2021

Aug 12, 2021

BUY
$56.61 - $80.46 $102,350 - $145,471
1,808 Added 0.4%
454,405 $28.6 Million
Q1 2021

May 13, 2021

BUY
$86.23 - $125.19 $484,008 - $702,691
5,613 Added 1.26%
452,597 $42.1 Million
Q4 2020

Feb 12, 2021

BUY
$79.17 - $111.47 $792,887 - $1.12 Million
10,015 Added 2.29%
446,984 $40.1 Million
Q3 2020

Nov 13, 2020

SELL
$81.91 - $134.94 $18.3 Million - $30.2 Million
-223,883 Reduced 33.88%
436,969 $45.2 Million
Q2 2020

Aug 14, 2020

SELL
$54.33 - $89.52 $3.23 Million - $5.32 Million
-59,432 Reduced 8.25%
660,852 $52.3 Million
Q1 2020

May 12, 2020

BUY
$49.34 - $68.76 $6.85 Million - $9.54 Million
138,804 Added 23.87%
720,284 $41.7 Million
Q4 2019

Feb 12, 2020

SELL
$51.21 - $59.06 $977,240 - $1.13 Million
-19,083 Reduced 3.18%
581,480 $31.4 Million
Q3 2019

Nov 14, 2019

BUY
$40.6 - $57.2 $3.59 Million - $5.05 Million
88,306 Added 17.24%
600,563 $31.4 Million
Q2 2019

Aug 13, 2019

BUY
$39.92 - $53.86 $1.79 Million - $2.41 Million
44,789 Added 9.58%
512,257 $24.7 Million
Q1 2019

May 14, 2019

BUY
$48.23 - $66.16 $9.88 Million - $13.6 Million
204,807 Added 77.97%
467,468 $23.6 Million
Q4 2018

Feb 12, 2019

BUY
$55.63 - $73.24 $14.6 Million - $19.2 Million
262,661 New
262,661 $15.6 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $515M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Atlanta Capital Management CO L L C Portfolio

Follow Atlanta Capital Management CO L L C and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlanta Capital Management CO L L C, based on Form 13F filings with the SEC.

News

Stay updated on Atlanta Capital Management CO L L C with notifications on news.